Auditory Perceptual Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The pediatric and adult versions of the SCAN-3 test (Keith, 2009a, 2009b) are widely used to screen and diagnose auditory processing disorders.
|
29800988 |
2018 |
Auditory Perceptual Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The outcomes of the SCAN-3 APD test battery, Swanson Nolan and Pelham-IV parental rating (SNAP-IV) and Children's Communication Checklist-2 (CCC-2) were analysed.
|
28964292 |
2017 |
Cytochrome-c Oxidase Deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The present study comprehensively analyzed a recently identified IMS protein cytochrome <i>c</i> oxidase assembly factor 7 (COA7), or RESpiratory chain Assembly 1 (RESA1) factor that is associated with a rare form of mitochondrial leukoencephalopathy and complex IV deficiency.
|
30885959 |
2019 |
Cytochrome-c Oxidase Deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
COA7 (C1orf163/RESA1) mutations associated with mitochondrial leukoencephalopathy and cytochrome c oxidase deficiency.
|
27683825 |
2016 |
Leukoencephalopathy
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The present study comprehensively analyzed a recently identified IMS protein cytochrome <i>c</i> oxidase assembly factor 7 (COA7), or RESpiratory chain Assembly 1 (RESA1) factor that is associated with a rare form of mitochondrial leukoencephalopathy and complex IV deficiency.
|
30885959 |
2019 |
Leukoencephalopathy
|
0.020 |
GeneticVariation
|
group |
BEFREE |
COA7 (C1orf163/RESA1) mutations associated with mitochondrial leukoencephalopathy and cytochrome c oxidase deficiency.
|
27683825 |
2016 |
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Talipes cavus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar Dysmetria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait, Drop Foot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hammer Toe
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Peripheral axonal neuropathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distal sensory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal amyotrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Foot dorsiflexor weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Attention deficit hyperactivity disorder
|
0.020 |
Biomarker
|
disease |
BEFREE |
Children with symptoms of combined ADHD plus LI performed significantly poorly (p < 0.05) compared to inattention ADHD plus LI in Filtered Words (FW) sub-test, but not in the rest of the SCAN-3 sub-tests.
|
28964292 |
2017 |
Attention deficit hyperactivity disorder
|
0.020 |
Biomarker
|
disease |
BEFREE |
The SCAN-3:C and SCAN-3:A test batteries were used to assess auditory processing abilities; Lucid Ability test for NVIQ; Children's Communication Checklist-2 (CCC-2) for language ability; Swanson Nolan and Pelham-IV Rating Scale (SNAP-IV) for ADHD; and the manual dexterity components of the Movement Assessment Battery for Children-2 (MABC-2) as a screening tool for DCD.
|
30262367 |
2018 |
Developmental Coordination Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
The SCAN-3:C and SCAN-3:A test batteries were used to assess auditory processing abilities; Lucid Ability test for NVIQ; Children's Communication Checklist-2 (CCC-2) for language ability; Swanson Nolan and Pelham-IV Rating Scale (SNAP-IV) for ADHD; and the manual dexterity components of the Movement Assessment Battery for Children-2 (MABC-2) as a screening tool for DCD.
|
30262367 |
2018 |